Together we will beat cancer

Donate

Stressed out – the cancer cells that survive chemotherapy, but at a cost

A group of Cancer Research UK-funded scientists are beginning to discover new vulnerabilities in cancer cells, which emerge when they enter ‘survival mode’.

Read More

Three new cancer drugs approved for NHS in Scotland

The three latest SMC decisions will provide new treatment options for some adults with non small cell lung cancer, multiple myeloma and a rare type of lymphoma.

Read More

Myeloma maintenance treatment not recommended on NHS in England

Cancer drug lenalidomide receives an initial rejection to treat some adults with myeloma following a stem cell transplant.

Read More

Three new cancer treatments available for NHS patients in Scotland

A breast cancer drug and two blood cancer treatments have been recommended for use on the NHS in Scotland.

Read More

Cancer drug approved for NHS use in England gives some multiple myeloma patients another option

A drug has been made available on the NHS in England for adults with a type of blood cancer called multiple myeloma who cannot receive standard treatment.

Read More

‘Game-changing’ myeloma drug combo approved for NHS use in England

A new treatment for people with multiple myeloma will now be available on the NHS in England.

Read More

NICE given grant to research patient preference

NICE will undertake a methodological study into patient health preferences after receiving a £120,000 grant courtesy of Myeloma UK.

Read More

Virtual reality and precision diagnosis among shortlist for our Grand Challenge

This entry is part 10 of 26 in the series Cancer Grand Challenges

Find out the details of the nine ideas that could answer one of our Grand Challenges in cancer prevention, diagnosis and treatment.

Read More

The cheek of it – how you could help beat blood cancer

Find out about blood stem cell donation, how you could get involved and even help save someone’s life

Read More

European blood cancer survival improving

Survival rates for people with blood cancer have improved across Europe, but variations still exist from country to country.

Read More